Table 2 Clinical presentation, complications, management, and outcomes in pediatric and adult groups
Pediatric (≤14y) (N=671) | Adult (>14y) (N=147) | P-value | |
|---|---|---|---|
Clinical presentation (%) | |||
Fever1 | 75.26 | 79.59 | 0.265 |
Cough | 92.00 | 89.10 | 0.265 |
Rhinorrhea | 15.10 | 10.90 | 0.191 |
Rhinobyon | 0.30 | 0.70 | 1.000 |
Conjunctivitis | 28.00 | 27.90 | 0.975 |
Erythra | 99.90 | 99.30 | 0.795 |
Koplik’s spots | 39.00 | 59.80 | ≤0.05 |
Stimson | 0.40 | 0.70 | 1.000 |
Complications (%) | |||
Gastroenteritis | 2.70 | 8.80 | ≤0.05 |
Measles encephalitis | 2.40 | 0.70 | 0.321 |
Pneumonia | 89.60 | 46.90 | ≤0.05 |
Pneumonia (bacterial) | 21.61 | 7.48 | ≤0.05 |
Pneumonia (viral) | 67.96 | 39.46 | ≤0.05 |
Myocarditis | 2.40 | 1.40 | 0.648 |
Management and outcomes | |||
Death (%) | 0.60 | 0.00 | 0.775 |
Antibiotic treatment (%) | 83.20 | 66.00 | ≤0.05 |
Antiviral treatment (%) Days2 median (IQR) | 13.70 6.00 (5,7) | 13.70 6.00 (5,7) | 0.997 0.740 |
Days3 median (IQR) | 6.00 (5,8) | 6.00 (4,7) | ≤0.05 |